Global mRNA Vaccines & Therapeutics Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global mRNA Vaccines & Therapeutics Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.

According to our (Global Info Research) latest study, the global mRNA Vaccines & Therapeutics market size was valued at US$ 4007 million in 2023 and is forecast to a readjusted size of USD 1450 million by 2030 with a CAGR of -13.7% during review period.

Global core mRNA vaccines & therapeutics manufacturers include Moderna Therapeutics, CureVac etc. The top 3 companies hold a share about 65%. Europe is the largest market, with a share about 10%, followed by Asia Pacific and North America.

This report is a detailed and comprehensive analysis for global mRNA Vaccines & Therapeutics market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:

Global mRNA Vaccines & Therapeutics market size and forecasts, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (USD/Doses), 2019-2030

Global mRNA Vaccines & Therapeutics market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (USD/Doses), 2019-2030

Global mRNA Vaccines & Therapeutics market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (USD/Doses), 2019-2030

Global mRNA Vaccines & Therapeutics market shares of main players, shipments in revenue ($ Million), sales quantity (M Doses), and ASP (USD/Doses), 2019-2024

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for mRNA Vaccines & Therapeutics

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global mRNA Vaccines & Therapeutics market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics, In-Cell-Art, eTheRNA, Ethris, Tiba Biotechnology, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

mRNA Vaccines & Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Infectious Disease Vaccines
Cancer Vaccines

Market segment by Application
Infectious Disease
Cancer

Major players covered
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe mRNA Vaccines & Therapeutics product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of mRNA Vaccines & Therapeutics, with price, sales quantity, revenue, and global market share of mRNA Vaccines & Therapeutics from 2019 to 2024.

Chapter 3, the mRNA Vaccines & Therapeutics competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the mRNA Vaccines & Therapeutics breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and mRNA Vaccines & Therapeutics market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of mRNA Vaccines & Therapeutics.

Chapter 14 and 15, to describe mRNA Vaccines & Therapeutics sales channel, distributors, customers, research findings and conclusion.